We are live on ! Find out more
SCA

Spearhead Capital Advisors Portfolio holdings

AUM $92.3M
1-Year Est. Return 18.16%
This Fund
S&P 500
This Quarter Est. Return
-5.97%
1 Year Est. Return
-18.16%
3 Year Est. Return
+25.24%
5 Year Est. Return
+54.04%
10 Year Est. Return
AUM
$808M
AUM Growth
-$20.8M
Cap. Flow
+$35.8M
Cap. Flow %
4.43%
Top 10 Hldgs %
31.44%
Holding
237
New
60
Increased
70
Reduced
61
Closed
44

Top Buys

Rank Stock Value
1
COIN icon
Coinbase
COIN
+$9.46M
2
DIS icon
Walt Disney
DIS
+$7.58M
3
ADBE icon
Adobe
ADBE
+$5.32M
4
CRM icon
Salesforce
CRM
+$5.02M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$4.1M

Sector Composition

Rank Sector Weight
1 Technology 16.68%
2 Healthcare 12.5%
3 Financials 10.48%
4 Consumer Staples 9.36%
5 Consumer Discretionary 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESGE icon
151
iShares ESG Aware MSCI EM ETF
ESGE
$6.58B
$272K 0.03%
+7,403
New +$284K
LOGI icon
152
Logitech
LOGI
$14.7B
$270K 0.03%
+3,663
New +$284K
CERS icon
153
Cerus
CERS
$433M
$268K 0.03%
48,770
-18,428
-27% -$102K
NEE icon
154
NextEra Energy
NEE
$181B
$268K 0.03%
3,164
-88
-3% -$7.05K
VEEV icon
155
Veeva Systems
VEEV
$33.1B
$268K 0.03%
1,262
-340
-21% -$73.8K
CLFD icon
156
Clearfield
CLFD
$411M
$265K 0.03%
+4,056
New +$255K
ONTO icon
157
Onto Innovation
ONTO
$12.9B
$265K 0.03%
+3,050
New +$271K
BL icon
158
BlackLine
BL
$1.84B
$263K 0.03%
3,590
-338
-9% -$27.3K
RGEN icon
159
Repligen
RGEN
$7.96B
$261K 0.03%
1,387
-715
-34% -$136K
SRPT icon
160
Sarepta Therapeutics
SRPT
$1.57B
$258K 0.03%
3,309
-1,875
-36% -$144K
TNDM icon
161
Tandem Diabetes Care
TNDM
$1.34B
$256K 0.03%
2,198
-2,423
-52% -$283K
ALRM icon
162
Alarm.com
ALRM
$2.71B
$254K 0.03%
3,823
-920
-19% -$65.1K
TWLO icon
163
Twilio
TWLO
$30B
$253K 0.03%
1,536
+153
+11% +$27.9K
QTRX icon
164
Quanterix
QTRX
$164M
$250K 0.03%
8,557
+2,024
+31% +$61.9K
ESTC icon
165
Elastic
ESTC
$6.84B
$246K 0.03%
2,760
-321
-10% -$28.7K
COHU icon
166
Cohu
COHU
$2.26B
$241K 0.03%
+8,126
New +$260K
FENY icon
167
Fidelity MSCI Energy Index ETF
FENY
$2.01B
$241K 0.03%
+11,523
New +$217K
SMAR
168
DELISTED
Smartsheet Inc.
SMAR
$240K 0.03%
4,381
-2,030
-32% -$116K
ARI
169
Apollo Commercial Real Estate
ARI
$867M
$239K 0.03%
+17,136
New +$231K
FLGT icon
170
Fulgent Genetics
FLGT
$470M
$237K 0.03%
3,804
-2,072
-35% -$136K
MED icon
171
Medifast
MED
$109M
$232K 0.03%
1,357
-517
-28% -$97.5K
UPWK icon
172
Upwork
UPWK
$1.13B
$231K 0.03%
9,930
+7
+0.1% +$175
DVAX
173
DELISTED
Dynavax Technologies
DVAX
$230K 0.03%
+21,263
New +$258K
VIR icon
174
Vir Biotechnology
VIR
$1.46B
$229K 0.03%
+8,892
New +$264K
ACMR icon
175
ACM Research
ACMR
$5.42B
$228K 0.03%
11,011
-3,446
-24% -$86.7K

Similar funds

Spearhead Capital Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Spearhead Capital Advisors held 237 positions worth $808M, down 2.5% from $828M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Spearhead Capital Advisors deployed $35.8M of net new capital in Q1 2022, opening 60 new positions and adding to 70 existing holdings. Its largest new stake was Coinbase: 48,405 shares worth $9.19M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vanguard Consumer Discretionary ETF, an estimated $2.95M trimmed.

  • Spearhead Capital Advisors's largest Q1 2022 buy was Coinbase: 48,405 shares worth $9.19M.
  • Spearhead Capital Advisors added most to Walt Disney in Q1 2022, an estimated $7.58M increase.
  • Spearhead Capital Advisors's biggest Q1 2022 reduction was Vanguard Consumer Discretionary ETF, cutting an estimated $2.95M.
  • Spearhead Capital Advisors fully exited Bank of America in Q1 2022, selling an estimated $11.3M.
  • Spearhead Capital Advisors's ten largest holdings make up 31% of its $808M portfolio in Q1 2022.
  • Spearhead Capital Advisors opened 60 new positions and closed 44 in Q1 2022.
  • Spearhead Capital Advisors's portfolio value fell 2.5% quarter-over-quarter to $808M.

Based on Spearhead Capital Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.